ZORZON, MARINO
 Distribuzione geografica
Continente #
NA - Nord America 5.533
EU - Europa 2.327
AS - Asia 776
SA - Sud America 10
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 8.657
Nazione #
US - Stati Uniti d'America 5.522
UA - Ucraina 778
IT - Italia 471
CN - Cina 315
SE - Svezia 301
FI - Finlandia 243
TR - Turchia 218
HK - Hong Kong 212
GB - Regno Unito 139
IE - Irlanda 115
BG - Bulgaria 114
FR - Francia 94
DE - Germania 30
BE - Belgio 21
IN - India 15
CA - Canada 11
IR - Iran 9
BR - Brasile 7
CH - Svizzera 7
NL - Olanda 6
AU - Australia 4
AT - Austria 2
EU - Europa 2
JP - Giappone 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SG - Singapore 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
HR - Croazia 1
KR - Corea 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 8.657
Città #
Fairfield 748
Jacksonville 673
Woodbridge 640
Wilmington 417
Houston 409
Ann Arbor 401
Ashburn 392
Chandler 341
Seattle 297
Cambridge 272
Princeton 228
Izmir 214
Hong Kong 212
Beijing 144
Sofia 114
Dublin 113
Milan 76
San Diego 49
Verona 48
Boardman 37
Dearborn 34
Buffalo 26
Bremen 23
Norwalk 23
Brussels 21
Chicago 21
Trieste 21
Washington 17
Helsinki 16
Venezia 16
Auburn Hills 10
Phoenix 10
Nanjing 9
Hefei 8
Rome 8
Toronto 8
Kunming 7
San Mateo 6
Augusta 5
Guangzhou 5
Leawood 5
Zhengzhou 5
Des Moines 4
Jinan 4
Monmouth Junction 4
Redwood City 4
Avellino 3
Bern 3
Birmingham 3
Falls Church 3
Gallarate 3
Hebei 3
Kocaeli 3
Mountain View 3
Mumbai 3
Pordenone 3
Redmond 3
Shenyang 3
Baotou 2
Chiari 2
Chongqing 2
Dakar 2
Dallas 2
Francavilla Al Mare 2
Fuzhou 2
Gurgaon 2
Hangzhou 2
Liebefeld 2
London 2
Los Angeles 2
Mestre 2
Mirano 2
Niterói 2
Prignano Cilento 2
Sollentuna 2
Sydney 2
Trani 2
Udine 2
Vienna 2
Zurich 2
Albinea 1
Ambato 1
Amsterdam 1
Ardabil 1
Arzano 1
Ascoli Piceno 1
Auckland 1
Bari 1
Buti 1
Canzo 1
Carlentini 1
Caserta 1
Costa Mesa 1
Dhaka 1
Dingle 1
Düsseldorf 1
Ferrara 1
Fremont 1
Genova 1
Gorey 1
Totale 6.245
Nome #
Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis. 207
Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue. 166
Optic Nerve and its Arterial-Venous Vascularization: An Ultrasonologic Study in Multiple Sclerosis Patients and Healthy Controls. 165
Bilingual aphasia and subcortical-cortical lesions. 145
Ultrasound findings of the optic nerve and its arterial venous system in multiple sclerosis patients with and without optic neuritis vs. healthy controls. 145
Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature. 138
Acute encephalopathy and polyneuropathy after disulfiram intoxication. 131
Mielite recidivante:esordio clinico di neuromielite ottica? 131
Depressive symptoms and MRI changes in multiple sclerosis 130
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. 127
Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996. 121
Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis. 121
MMP-9 microsatellite polymorphism and multiple sclerosis. 117
Trigeminal neuralgia due to contralateral meningioma of the posterior cranial fossa. 116
Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy. 114
HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. 114
Chronic bilateral electrical stimulation of the subthalamic nucleus for the treatment of advanced Parkinson's disease 113
Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis. 112
Proton magnetic resonance spectroscopy during transient global amnesia 112
SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS. II. CORRELATION ANALYSIS 107
SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS. A CASE-CONTROL STUDY. I. FREQUENCY AND COMPARISON OF GROUPS 106
A longitudinal study of brain atrophy and cognitive disturbances in early phase of relapsing-remitting multiple sclerosis 106
Immediate prognosis of primary intracerebral hemorrhage using an easy model for the prediction of survival. 106
Short-term brain atrophy changes in relapsing-remitting multiple sclerosis. 104
Sexual dysfunction in multiple sclerosis: a 2-year follow-up study 104
CORRELATION OF SEXUAL DYSFUNCTION AND BRAIN MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS 102
Headache induced by Chronic substance use:analysis of medication overused and minimum dose required to induce headache. 101
A longitudinal study of quality of life and side effects in patients with Multiple Sclerosis treated with Interferon beta-1a. 101
Efficacia del mesoglicano nella terapia della placca ateromasica dei vasi epiaortici 101
OLFACTORY LOSS IN MULTIPLE SCLEROSIS 100
HLA GENOTYPES AND DISEASE SEVERITY ASSESSED BY MAGNETIC RESONANCE IMAGING FINDINGS IN PATIENTS WITH MULTIPLE SCLEROSIS. 99
Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. 98
Nontraumatic headache in the Emergency Department: a survey in the province of Trieste. 96
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS 96
Acute akinesia, an unusual complication in Parkinson’s disease: a case report 95
Outcome of medication overuse headache after abrupt in-patient withdrawal. 94
Effect of intravenous methylprednisolone in the number, size and confluence of plaques in relapsing-remitting multiple sclerosis. 93
Prevalence of migraine in Croatia: a population-based survey. 92
Familial and environmental risk factors in Parkinson's disease: a case control study in North-East Italy. 92
Risk factors of multiple sclerosis:a case-control study. 91
Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis. 91
Hyperglycemia at ischemic stroke onset as prognostic factor. 91
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression. 89
Transient global amnesia and transient ischemic attack. Natural history, vascular risk factors, and associated conditions. 89
Sexual dysfunction in multiple sclerosis. A MRI, neurophysiological and urodynamic study 88
Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. 87
Migraine and tension-type headache in Croatia: a population-based survey of precipitating factors. 87
MRI TECHNIQUES AND COGNITIVE IMPAIRMENT IN EARLY PHASE OF RELAPSING-REMITTING MULTIPLE SCLEROSIS 86
Sclerosi multipla in overlap con sindrome di Sjogren 85
Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis. 84
Persistent aura without infarction:description of the first case studied with both brain SPECT and perfusion MRI. 82
Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis. 81
Hypnic headache:rapid and long-lasting response to prednisone in two new cases. 79
Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis 75
Magnetic resonance imaging techniques as predictors of cognitive impairment in multiple sclerosis 70
Clinical surveillance of patients with multiple sclerosis 68
Incidence and prevalence of motor neuron disease in Coastal and Mountanious Regions, Croatia, 1984-1993. A preliminary survey. 68
Aritmie cardiache ed ischemia cerebrale acuta. Studio con monitoraggio Holter 68
Epstein-Barr Virus is Associated with Gray Matter Atrophy in Multiple Sclerosis 68
Approccio multidisciplinare alla Sclerosi Multipla. SPSM-RIabilitazione 65
Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjectsJ 64
Central nervous system atrophy in Multiple Sclerosis: Introduction. 61
Beta 2-microglobulin level is not a marker of disease activity in Multiple Sclerosis. 61
Increased density in the middle cerebral artery by nonenhanced computed tomography. Prognostic value in acute cerebral infarction. 61
Atrial fibrillation and acute ischemic cerebrovascular disease. Study of 500 cases of cerebral infarction and transient cerebral ischemic attacks 61
Trattamento con cicli di megadosi di metilprednisolone in pazienti affetti da sclerosi multipla cronico-progressiva: valutazione clinica a tre anni 60
La rieducazione equestre: una possibilità riabilitativa 59
Fattori prognostici nell'emorragia cerebrale primitiva sopratentoriale 59
Concordance of carotid bruit and positivity of computerized digital angiography of the epiaortic vessels in carotid stenotico-occlusive pathology 58
Aspetti epidemiologici e clinici dello stroke. 57
L'aderenza alla terapia nella sclerosi multipla. Il punto di vista del medico 53
THE USE OF STANDARDIZED INCIDENCE AND PREVALENCE RATES IN EPIDEMIOLOGICAL STUDIES ON MULTIPLE SCLEROSIS. A META-ANALYSIS STUDY 52
Cysts of the atlantoaxial joint: excellent long-term outcome after posterolateral surgical decompression. Report of two cases. 51
Ematocrito, emoglobina, numero di globuli rossi e bianchi in rapporto al rischio di insorgenza delle vasculopatie cerebrali acute di tipo ischemico 51
Proton magnetic resonance spectroscopy study of ischemia in intracerebral hemorrhage 50
Le crisi ischemiche cerebrali transitorie e prolungate (TIA e RIND) 49
Fumo di sigaretta e rischio d'insorgenza delle vasculopatie cerebrali acute di tipo ischemico 48
The latero-cervical murmur. Clinical and etiological observations on 515 cases belonging to a group of 2782 subjects examined 47
Side-effects and changes in systemic arterial pressure after administration of a single dose of lorazepam 47
Prevention and therapy of delirium tremens with tiapride 47
Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis. A clinical and MRI study 46
Terapia antiossidante nell’ictus ischemico acuto 46
Update sul Teriflunomide 46
Use of ticlopidine in patients with acute non-embolic cerebral infarcts 45
The blood level of uric acid as a risk factor in transient cerebral ischemic attacks and in non-embolic acute cerebral infarct 45
Nyctohemeral incidence of acute cerebral vasculopathies 45
Disabilità e Qualità della Vita nelle persone colpite da Sclerosi Multipla 45
Frontal parenchimal atrophy measures in multiple sclerosis. 44
Normalized regional brain atrophy measures in multiple sclerosis 44
Gaucher’s disease with Parkinson’s disease: Clinical and pathological aspects 44
Case Report: Coexistence of SUNCT and Hypnic Headache in the Same Patient 44
Dyslipidemias and ischemic cerebral vasculopathies 43
Reliability of Doppler ultrasonography in relation to computerized digital angiography in patients with carotid bruit 42
SFAAT: Studio della fibrillazione atriale cronica non reumatica nell’area triestina. Risultati dell’arruolamento 42
Recurrent atrial fibrillation associated with pulse administration of high doses of methylprednisolone: a possible prophylactic treatment. 41
Migraine crisis and neurological focal signs of slow or absent resolution (complicated migraine) 41
The electroencephalogram and lacunar infarcts 41
Relationship between central nervous system atrophy and genetic-immunological markers in Multiple Sclerosis 40
Ticlopidine and pentoxifylline in acute cerebral infarct. Clinical study on 151 patients 40
Familial nature of acute cerebral vasculopathies of the ischemic type 40
Totale 8.170
Categoria #
all - tutte 23.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.107


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019895 0 0 0 0 0 0 0 0 0 113 584 198
2019/20201.834 102 75 79 362 111 271 173 249 133 87 154 38
2020/20211.412 132 60 129 185 35 217 119 145 27 149 64 150
2021/2022852 28 95 12 92 4 32 31 58 143 106 100 151
2022/20231.175 136 68 130 142 117 255 29 89 153 3 43 10
2023/2024642 27 29 35 57 132 44 45 236 6 31 0 0
Totale 8.700